Pharmaceutical

Every Cure Receives Five-Year, $60 Million Commitment Through TED’s Audacious Project to Repurpose Medications for Global Impact

PHILADELPHIA, Oct. 9, 2024 /PRNewswire/ -- Every Cure, an AI-powered nonprofit biotech organization, has received a five-year $60 million commitment through…

1 year ago

ProofPilot Welcomes Roslyn Schneider to Advisory Board

NEW YORK, Oct. 9, 2024 /PRNewswire/ -- ProofPilot, the industry's first end-to-end Clinical Experience Platform (CXP), purpose-built for recruitment and…

1 year ago

BuzzRx® Unveils Insights From New “State of Our Health” Data Report

In-Depth Exploration of Five Key Topics for October's Awareness Month Themes FORT LAUDERDALE, Fla., Oct. 9, 2024 /PRNewswire/ -- BuzzRx,…

1 year ago

Verseon Develops Superior Approach in Combining AI Models for Greater Accuracy

Peer-reviewed paper describes novel ensembling technique that offers 150% improvement over current state of the art FREMONT, Calif., Oct. 9,…

1 year ago

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

Regulatory and Compliance excellence recognized for innovation across the product development lifecycle RALEIGH, N.C., Oct. 9, 2024 /PRNewswire/ -- ProPharma,…

1 year ago

Dignify Therapeutics welcomes leading healthcare entrepreneurs Howard Palefsky and Neil Kurtz, MD to its Board of Directors

RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and…

1 year ago

Lexaria’s GLP-1 Human Pilot Study #3 Begins Dosing

DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / October 9, 2024…

1 year ago

MedCana Highlights Recent Acquisitions and the Multiple Cannabis Licenses Associated with Each

The licenses will add $1.6 million to our total Assets for the 3rd Quarter. AUSTIN, TX / ACCESSWIRE / October…

1 year ago

180 Life Sciences Corp. Regains Compliance with Nasdaq’s Minimum Stockholders’ Equity Rule and Expands into the Global iGaming Sector

PALO ALTO, CA / ACCESSWIRE / October 9, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF) (the "Company" or "180"), is…

1 year ago

Releaf & SOMAÍ Unite in Exclusive UK Cannabis Deal

Releaf® Announces Partnership with SOMAÍ Pharmaceuticals to Bring Innovative Cannabis Solutions to UK Patients NOTTINGHAM, ENGLAND / ACCESSWIRE / October…

1 year ago